Press Releases :: Graphite Bio, Inc. (GRPH)

Feb 24, 2021 8:30am EST

Graphite Bio Expands Leadership Team with Appointment of Jerry Cacia as Chief Technical Officer

Jan 13, 2021 8:35am EST

Jasper Therapeutics and Graphite Bio Announce Collaboration to Evaluate JSP191 as Conditioning Regimen for Novel Gene Replacement Therapy in Patients with XSCID

Jan 08, 2021 4:44pm EST

Graphite Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

Dec 21, 2020 8:30am EST

Graphite Bio Appoints Pharmaceutical Industry Veterans to Board of Directors

Dec 14, 2020 8:30am EST

Graphite Bio Receives IND Clearance to Initiate Clinical Trial for Next-Generation Gene Editing Therapy GPH101 in Sickle Cell Disease

Nov 09, 2020 8:30am EST

Graphite Bio Expands Leadership Team with Accomplished Pharmaceutical Executives to Advance Programs to the Clinic and to Achieve Continued Business Growth

Sep 16, 2020 8:00am EDT

Graphite Bio Launches with $45 Million Series A Financing

rss_feed News RSS

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Graphite Bio, its subsidiaries or affiliates. No use of any Graphite Bio trademark, trade name, or trade dress in this site may be made without the prior written authorization of Graphite Bio, except to identify the product or services of the company.

©Copyright 2021 Graphite Bio, Inc. All rights reserved.